Activation of alpha 7 nicotinic acetylcholine receptor protects mice from radiation-induced intestinal injury and mortality

Radiation Research

Volumn 181, Issue 6, 2014, Pages 666-671

  Chen, Ji Kuai ^a   Li, Zhang Peng ^a   Liu, Yun Zi ^a   Zhao, Ting ^a   Zhao, Xin Bin ^a   Ni, Min ^a   Jiang, Guo Jun ^b   Shen, Fu Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Zhejiang Xiaoshan Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; AMIFOSTINE; BUNGAROTOXIN RECEPTOR; METHYLLYCACONITINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DEPRESSION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE INJURY; MORTALITY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INDUCED INTESTINAL INJURY; RADIATION INJURY; SURVIVAL; UMBILICAL VEIN ENDOTHELIAL CELL; WHOLE BODY RADIATION;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; HUMANS; INTESTINES; MALE; MICE; RADIATION INJURIES; WHOLE-BODY IRRADIATION; WOUNDS AND INJURIES;

EID: 84902499430     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13575.1     Document Type: Article

References (24)

1. Pandey BN, Kumar A, Tiwari P, Mishra KP. Radiobiological basis in management of accidental radiation exposure. Int J Radiat Biol 2010; 86:613-35.
2. Mettler FA Jr, Voelz GL. Major radiation exposure-what to expect and how to respond. N Engl J Med 2002; 346:1554-61.
3. Zhao W, Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 2009; 16:130-43.
4. Lorimore SA, Rastogi S, Mukherjee D, Coates PJ, Wright EG. The influence of p53 functions on radiation-induced inflammatory bystander-type signaling in murine bone marrow. Radiat Res 2013; 179:406-15.
5. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33:781-96.
6. Bush MA, Samara E, Whitehouse MJ, Yoshizawa C, Novicki DL, Pike M, et al. Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease. J Clin Pharmacol 2001; 41:378-85.
7. Bonnaud S, Niaudet C, Legoux F, Corre I, Delpon G, Saulquin X, et al. Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. Cancer Res 2010; 70:9905-15.
8. Kim SB, Ly P, Kaisani A, Zhang L, Wright WE, Shay JW. Mitigation of radiation-induced damage by targeting egfr in noncancerous human epithelial cells. Radiat Res 2013; 180:259-67.
9. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-8.
10. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009; 9:418-28.
11. Li DJ, Evans RG, Yang ZW, Song SW, Wang P, Ma XJ, et al. Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension. Hypertension 2011; 57:298-307.
12. Liu C, Shen FM, Le YY, Kong Y, Liu X, Cai GJ, et al. Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor. Crit Care Med 2009; 37:634-41.
13. Parada E, Egea J, Romero A, del BL, Garcia AG, Lopez MG. Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via alpha7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway. Free Radic Biol Med 2010; 49:1815-21.
14. Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008; 29:151-8.
15. Bodnar AL, Cortes-Burgos LA, Cook KK, Dinh DM, Groppi VE, Hajos M, et al. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. J Med Chem 2005; 48:905-8.
16. Ward JM, Cockcroft VB, Lunt GG, Smillie FS, Wonnacott S. Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites. FEBS Lett 1990; 270:45-8.
17. Brizel DM. Pharmacologic approaches to radiation protection. J Clin Oncol 2007; 25:4084-9.
18. Terry NH, Travis EL. The influence of bone marrow depletion on intestinal radiation damage. Int J Radiat Oncol Biol Phys 1989; 17:569-73.
19. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293:293-7.
20. Cho CH, Kammerer RA, Lee HJ, Yasunaga K, Kim KT, Choi HH, et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci U S A 2004; 101:5553-8.
21. Marrero MB, Bencherif M. Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Res 2009; 1256:1-7.
22. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002; 105:788-93.
23. Weiss JF. Pharmacologic approaches to protection against radiation-induced lethality and other damage. Environ Health Perspect 1997; 105 Suppl 6:1473-8.
24. Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008; 320:226-30.